Diabetes decisions — 2025

The Board denied service connection for the cause of the Veteran's death, finding no evidence that his cardiomyopathy or other conditions were related to military service, including exposure to herbicides.

The appeal for an earlier effective date for service connection for diabetes mellitus, type II associated with herbicide exposure was dismissed as a matter of law.

The Board denied the veteran's claim for service connection for diabetic retinopathy, finding no current disability and that the condition was not caused or aggravated by his service-connected diabetes mellitus type II with hypertension.

The Board remands the Veteran's claims for service connection for diabetes mellitus type II, hypertension, loss of organ, gallbladder, and loss of organ, small intestine due to pre-decisional duty-to-assist errors.

The Board granted service connection for hypertension and diabetes mellitus type 2 based on the Veteran's exposure to herbicide agents, as provided by the PACT Act.

The Board remands the claims for a higher disability rating and TDIU due to insufficient evidence of record.

The appeal was dismissed due to the appellant's death during the pendency of the appeal.

The Board denied the veteran's claim for service connection for diabetes mellitus, type II, finding that there was no evidence of in-service incurrence or a nexus to service.

The Board denied service connection for bilateral hearing loss but granted readjudication of claims for hypertension and diabetes mellitus type II, and remanded several other conditions including PTSD, liver disorder, and pancreatitis.

The Board remands the claims for service connection for diabetes mellitus, type 2, hyperlipidemia, and hypertension due to inadequate VA examinations.

The Board denied service connection for tinnitus and remanded the claims for service connection for left knee, right knee, left shoulder, thoracolumbar spine, foot, psychiatric disorder, and diabetes mellitus type II.

The Board denied service connection for multiple conditions, including cervicalgia, left and right hip disabilities, right ankle disability, diabetes mellitus, neuropathy of the lower and upper extremities, and a skin disability. The claim was also granted for a 20 percent rating for left ankle sprain with chronic achilles tendonitis and degenerative arthritis.

The Board granted service connection for diabetes mellitus as secondary to service-connected hypertension and denied a compensable rating for erectile dysfunction, while remanding claims for higher ratings and additional service connections.

The Board granted service connection for type II diabetes mellitus and bilateral diabetic peripheral neuropathy of the lower extremities, both on a presumptive basis due to herbicide agent exposure during service.

The appeal for restoration of a 70 percent rating for anemia is granted, effective July 1, 2022. The other claims for increased ratings and TDIU are denied.

The appeal was dismissed due to the Veteran's death during the pendency of the appeal.

The Board denied the Veteran's claims for earlier effective dates for service connection grants under the PACT Act, as the earliest available date is August 10, 2022.

The Board remands the claims for service connection and rating appeals to cure pre-decisional duty-to-assist errors.

The Board denied the veteran's claim for service connection for diabetes mellitus, type II, finding that there was no evidence of in-service incurrence or a nexus to service.

The Board granted service connection for prostate cancer, diabetes mellitus II, tumor on pituitary gland, and hypertension under the PACT Act. The skin condition and special monthly compensation claims were remanded.